THE ACTION OF THE DNA INTERCALATING AGENTS 4'-(9-ACRIDINYLAMINO) METHANESULPHON-M-ANISIDIDE AND 1,4-BIS(BUTYLAMINO) BENZO[G]PHTHALAZINE IN U-937 HUMAN PROMONOCYTIC CELLS - RELATIONSHIP BETWEEN CELL-CYCLE AND DIFFERENTIATION
C. Perez et al., THE ACTION OF THE DNA INTERCALATING AGENTS 4'-(9-ACRIDINYLAMINO) METHANESULPHON-M-ANISIDIDE AND 1,4-BIS(BUTYLAMINO) BENZO[G]PHTHALAZINE IN U-937 HUMAN PROMONOCYTIC CELLS - RELATIONSHIP BETWEEN CELL-CYCLE AND DIFFERENTIATION, Biochemical pharmacology, 48(1), 1994, pp. 75-82
The action of two structurally related DNA intercalating agents has be
en studied and compared, namely 4'-(9-acridinylamino) methanesulphon-m
-anisidide (amsacrine, mAMSA) and 1,4-bis(butylamino)benzo[g]phthalazi
ne (ABP) on the cell cycle and differentiation of U-937 human promonoc
ytic leukemia cells. mAMSA (0.1 mu M) and ABP (4 mu M) reduced the pro
liferation activity to a similar extent and caused little cell mortali
ty. At these subcytotoxic concentrations mAMSA induced the cells to ac
cumulate at the G(2) phase of the cycle, while cycle inhibition provok
ed by ABP was not phase specific. In addition, mAMSA caused an increas
e in the cell mass while ABP provoked cell shrinkage. This was consist
ent with the fact that ABP considerably inhibited protein synthesis, w
hile mAMSA did not significantly affect this activity. SDS/K(+)DNA pre
cipitation assays indicated that mAMSA, but not ABP, stimulated protei
n-DNA covalent complex formation. Finally, it was found that mAMSA, bu
t not ABP, elicited the expression of differentiation markers, namely
nitroblue tetrazolium reduction, activation of vimentin and leukocyte
integrin (CD11b/CD18 and CD11c/CD18) expression, and downregulation of
c-myc expression. The DNA intercalators doxorubicin and mitoxantrone,
which like mAMSA induced the cells to accumulate at the G(2) phase an
d increased the cell mass, induced the expression of differentiation m
arkers. In contrast, the intercalators aclarubicin and caffeine and th
e non-intercalator novobiocin, which produced minor alterations on cel
l-cycle distribution and caused cell shrinkage, did not significantly
elicit differentiation. These results support the conclusion that diff
erentiation of myeloid leukemia cells by cytostatic drugs depends on t
he perturbations of the cell cycle, leading to disproportionate increa
ses in cell mass.